Target intelligence / Profile preview

Parasite lipid membrane

Molecular classification
Cell membrane, Lipid bilayer
01

Overview

Parasite lipid membranes are complex, dynamic structures that define the boundary of the parasite, playing a vital role in maintaining osmotic balance, acquiring nutrients from the host, and mediating signal transduction (Source: Journal of Lipid Research). These membranes often contain unique lipid species or sterols, such as ergosterol in many protozoa, which are absent in human cells and thus serve as selective targets for chemotherapy (Source: Nature Reviews Microbiology). For example, the polyene antifungal Amphotericin B exploits the presence of ergosterol to induce pore formation and subsequent parasite lysis (Source: StatPearls). Other agents like miltefosine, an alkylphosphocholine, interfere with phospholipid metabolism and membrane-anchored signaling (Source: WHO). While effective, targeting the lipid membrane is often limited by the structural similarities between parasite and host lipids, which can lead to significant adverse effects such as hemolysis and renal impairment (Source: PubMed). Understanding the specific lipidomic profile of different parasites remains a key area for developing more selective and less toxic anti-parasitic interventions.

Other names
Parasitic plasma membraneProtozoan cell membraneHelminthic membraneParasite cell membrane
02

Mechanism of action

Drugs targeting the parasite lipid membrane typically function by binding to specific membrane components like ergosterol or phospholipids, leading to the formation of aqueous pores, alteration of membrane fluidity, or disruption of lipid-mediated signaling pathways, which results in the loss of intracellular contents and cell death (Source: StatPearls, PubMed).

03

Biological functions

Barrier functionNutrient transportOsmotic regulationSignal transductionHost-cell interaction
04

Disease associations

InfectionLeishmaniasisMalariaTrypanosomiasisAmoebiasisSchistosomiasis
05

Safety considerations

Off-target toxicity to host cell membranesHemolysisNephrotoxicityLow therapeutic indexPotential for rapid development of resistance via lipid remodeling
06

Interacting drugs

Amphotericin B

4 more in the full profile.

07

Biomarkers

Parasitemia levelsLactate dehydrogenase (LDH) releaseMembrane sterol composition

Beyond the preview

Go deeper on Parasite lipid membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasite lipid membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call